Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The role of CHD7 in human central nervous system development (ChIP-Seq)

ABSTRACT: The role of CHD7 in human central nervous system development (ChIP-Seq)

PROVIDER: PRJNA427521 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6491720.fastq.gz	Fastqsanger.gz
	SRR6491730.fastq.gz	Fastqsanger.gz
	SRR6491740.fastq.gz	Fastqsanger.gz
	SRR6491750.fastq.gz	Fastqsanger.gz
	SRR6491760.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 110

Similar Datasets

The role of CHD7 in human central nervous system development (ChIP-Seq)

Project description:CHARGE syndrome is a congenital disorder caused by mutations in Chromodomain Helicase DNA-binding domain 7 (CHD7) gene. We generated a cell line carrying HA-tag knock-in into the human CHD7 locus, mediated by CRISPR-Cas9 system. We then performed ChIP against HA antibody using the validated knock-in cells and subsequent high-throughput sequencing analysis.

2018-03-28 | GSE108506 | GEO

Efavirenz Central Nervous System Side Effects

Project description:Efavirenz Central Nervous System Side Effects

| PRJNA354669 | ENA

Prox1 inhibits axon outgrowth during central nervous system development

Project description:Prox1 inhibits axon outgrowth during central nervous system development

| PRJNA666924 | ENA

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Project description:RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 monoclonal antibody 3F8, can find tumor cells and carry tumor-killing substances to them without harming normal cells. This may be an effective treatment for central nervous system cancer or leptomeningeal metastases. PURPOSE: This phase II trial is studying the side effects and how well iodine I 131 monoclonal antibody 3F8 works in treating patients with central nervous system cancer or leptomeningeal cancer.

| 2037925 | ecrin-mdr-crc

Genomic aberrations in primary central nervous system lymphoma (PCNSL)

Project description:Genomic aberrations in primary central nervous system lymphoma (PCNSL). Two-condition experiment, PCNSLs vs. healthy men. Biological replicates: 12 tumors replicates, 13 peripheral blood replicates.

2010-11-13 | E-GEOD-25298 | biostudies-arrayexpress

Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma

Project description:This SuperSeries is composed of the following subset Series: GSE25297: Genome-wide gene expression comparison (primary central nervous system lymphoma (PCNSL) vs normal lymph node) GSE25298: Genomic aberrations in primary central nervous system lymphoma (PCNSL) Refer to individual Series

2010-11-13 | E-GEOD-25299 | biostudies-arrayexpress

Genomic aberrations in primary central nervous system lymphoma (PCNSL)

Project description:Genomic aberrations in primary central nervous system lymphoma (PCNSL).

2010-11-13 | GSE25298 | GEO

GM-CSF in the central nervous system

Project description:The functional outcome of GM-CSF in the central nervous system

| PRJEB27657 | ENA

The brain regulatory program predates central nervous system evolution

Project description:The brain regulatory program predates central nervous system evolution

| PRJNA903823 | ENA

The Cryptococcal Central Nervous System Transcriptome during Human Disease

Project description:The Cryptococcal Central Nervous System Transcriptome during Human Disease